期刊文献+

术中富集骨髓细胞构建组织工程骨成骨能力的研究 被引量:1

Osteogenic effect of tissue-engineered bone constructed by poly-L-lysine-demineralized bone matrix enriched bone marrow cells
原文传递
导出
摘要 目的观察术中富集骨髓千细胞构建的组织工程骨在山羊脊柱横突间融合的成骨效果,为组织工程骨探索一种新型的构建方法。方法将多聚左旋赖氨酸(poly—L—lysine,PLL)修饰于山羊脱钙骨基质(demineralized bone matrix,DBM)制备成基质材料(PLL—DBM);以山羊横突间隙为植骨模型,观察PLL-DBM富集骨髓细胞构建的组织工程骨(ⅠA组)的成骨能力;对照组为自体髂骨组(ⅠB组)、DBM富集骨髓组(ⅡC组)、空白DBM组(ⅡD组)。于术后第16周取融合段标本行X线片、三维CT及CT值检测和生物力学检测,对比分析、评价其成骨能力。结果X线表现:ⅠA组、ⅠB组融合范围基本相同,明显较ⅡC组宽,ⅡD组基本无融合。三维CT:ⅠA组的CT值为(696.76±102.75)HU,ⅠB组的CT值为(766.03±69.24)HU,二者差异无统计学意义(P〉0.05),均明显较ⅡC组高(P〈0.05),ⅡC组CT值较ⅡD组高(P〈0.01)。生物力学性能:ⅠA、ⅠB两组最大载荷、抗弯强度比较差异均无统计学意义(P〉0.05),ⅠA组较ⅡC组高(P〈0.01,0.05),ⅠB组较ⅡC组高(P〈0.01),ⅡC组较ⅡD组高(P〈0.01)。结论PLL—DBM术中富集骨髓干细胞快速构建的组织工程骨是一种理想的组织工程骨,其成骨能力与自体髂骨相当。 Objective To observe the osteogcnic effect of tissue-engineered bone constructed by poly-L-lysine-demineralized bone matrix (PLL-DBM) enriched hone marrow stem cells in the space of goat transverse process bone fusion model and explore a new tissue-engineered bone construction method. Methods PLL was used to decorate goat DBM to prepare a matrix material (PLL-DBM). The osteogenic effect of tissue-engineered bone constructed by PLL-DBM enriched bone marrow cells ( Group Ⅰ A) was detected in goat lumbar intertransvcrse graft bone model; autogeuous iliac bone (Group ⅠB) , DBM enriched bone marrow (Group ⅡC) and DBM (Group ⅡD) were used as controls. The osteogenesis of the bones in the fused segments of four groups were compared and evaluated by X-ray, three-dimensional CT, CT value testing and biomechanical testing. Results The results of X-ray showed that the fusion ranges in groups ⅠA and ⅠB were basically the same, which were significantly wider than that in Group Ⅱ, with no fusion detected in Group ⅡD. The CT value was (696.76 ±10275 ) HU in Group Ⅰ A and (766.03 ±69.24) HU in Group B, which were significantly higher than that in Group Ⅱ C (P 〈 0. 05), but there was no statistical difference in CT value between Groups Ⅰ A and ⅠB ( P 〉 0.05 ). The CT value in Group Ⅱ C was significantly higher than in Group ⅡD (P 〈0.01 ). There was no statistical difference between Groups ⅠA and ⅠB in the maximum load and bending strength ( P 〉 0.05 ). The maximum load and bending strength in Groups Ⅰ A and ⅠB were significantly higher than that in Group Ⅱ C (P 〈 0.05 ), and the two indices in Group Ⅱ C were significantly higher than that in Group Ⅱ D ( P 〈0. 01). Conclusion Tissue-engineered bone constructed by PLL-DBM enriched bone marrow cells is an ideal tissue engineered bone and its osteogenic potential is similar to that of autologous bone.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2009年第8期743-747,共5页 Chinese Journal of Trauma
基金 国家高技术研究发展计划重大攻关课题资助项目(2006AA02A122)
关键词 骨髓祖代细胞 骨基质 脱钙 组织工程 Myeloid progenitor cells Bone matrix, demineralized Tissue engineering
  • 相关文献

参考文献15

  • 1Xie H, Yang F, Deng L, et al. The performance of a bone - derived scaffold material in the repair of critical bone defects in a rhesus monkey model. Biomaterials, 2007, 28 (22) :3314 - 3324.
  • 2Block JK. The role and effectiveness of bone marrow in osseous regeneration. Med Hypotheses, 2005, 65 (4) :740 - 747.
  • 3Kotobuki N, Hirose M, Takakura Y, et al. Cultured autologous human cells for ham tissue regeneration : preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs, 2004, 28(1) :33 -39.
  • 4Ohgushi H, Kitamura S, Kotobiuki N, et al. Clinical application of marrow mesenchymal stem cells for hard tissue repair. J Yonsei Med, 2004, 45 Suppl:61 - 67.
  • 5Maddox E, Zhan M, Mundy GR, et al. Optimizing human demineralized bone matrix for clinical application. J Tissue Eng, 2000, 6(4) :441 -448.
  • 6刘曦明,许建中,陈庄洪,李世普,罗飞,曾玲,刘杰.新型骨髓干细胞富集材料的制备及其表征研究[J].华南国防医学杂志,2008,22(2):9-11. 被引量:7
  • 7Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow : the influence of aspiration volume. J Bone Joint Surg ( Am), 1997, 79 ( 11 ) : 1699 - 1709.
  • 8Muschler GF, Nitto H, Matsukura Y, et al. Spine fusion using cell matrix composites enriched in bone marrow - derived cells. Clin Orthop, 2003, (407) :102 - 118.
  • 9Muschler GF, Matsukura Y, Nitro H, et al. Selective retention of bone marrow- derived cells to enhance spinal fusion. Clin Orthop Relat Res, 2005, (432): 242-251.
  • 10刘曦明,许建中,陈庄洪,罗飞,曾玲,刘杰,叶青.PLL-DBM支架材料富集骨髓有核细胞的效果评价[J].华南国防医学杂志,2008,22(2):12-14. 被引量:3

二级参考文献38

  • 1刘杰,许建中,王序全,罗飞.脱钙骨基质支架构建组织工程骨的实验研究[J].第三军医大学学报,2005,27(9):888-891. 被引量:13
  • 2李章华,廖文,刘世清,张玉富,王常勇,赵强.组织工程骨修复节段性骨缺损的实验研究[J].中华整形外科杂志,2006,22(1):55-59. 被引量:5
  • 3干耀恺,戴尅戎,张蒲,汤亭亭,郝永强,唐坚,史定伟,王友,孙月华,朱振安.应用富集骨髓干细胞技术治疗骨缺损[J].中华骨科杂志,2006,26(11):721-727. 被引量:31
  • 4[1]Hernigou P,Poignard A,Manicom O,et al.The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone[J].J Bone Joint Surg Br,2005,87(7):896-902
  • 5[2]Brodke D,Pedrozo HA,Kaput TA,et al.Bone grafts prepared with selective cell retention technology heal canine segmental defects as effectively as autograft[J].J Orthop Res,2006,24(5):857-866
  • 6[3]Block JE.The role and effectiveness of bone marrow in osseous regeneration[J].Med Hypotheses,2005,65(4):740-747
  • 7[4]Kitchel SH,Wang MY,Lauryssen CL.Techniques for aspirating bone marrow for use in spinal surgery[J].Neurosurgery,2005,57(4 suppl):286-289
  • 8[5]Muschler GF,Matsukura Y,Nitto H,et al.Selective retention of bone marrow-derived cells to enhance spinal fusion[J].Clin Orthop Relat Res,2005,(432):242-251
  • 9[7]Maddox E,Zhan M,Mundy GR,et al.Optimizing human demineralized bone matrix for clinical application[J].Tissue Eng,2000,6(4):441-448
  • 10[8]Zhang R,Ma PX.Porous poly(L-lactic acid)/apatite composites created by biomiminetic process[J].J Biomed Mater Res,1999,45(4):285-293

共引文献33

同被引文献34

  • 1干耀恺,戴尅戎,张蒲,汤亭亭,郝永强,唐坚,史定伟,王友,孙月华,朱振安.应用富集骨髓干细胞技术治疗骨缺损[J].中华骨科杂志,2006,26(11):721-727. 被引量:31
  • 2Bratt-Leal AM, Carpenedo RL, oid body microenvironment to McDevitt TC. Engineering the embry- direct embryonic stem cell differentiation. Biotechnol Prog, 2009, 25( 1): 43-51.
  • 3Hyslop LA, Armstrong L, Stojkovic M, et al. Human embryonic stem cells: biology and clinical implications. Expert Rev Mol Med, 2005, 7(19): 1-21.
  • 4Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 2006, 24(5): 1294-1301.
  • 5Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem, 2001, 82(4): 583-590.
  • 6Wiodarski KH, Wlodarski PK, Galus R. Senescence of osteogenic cells. Review. Orthop Traumatol Rehabil, 2007, 9(1): 63-67.
  • 7Wehner R, Wehrum D, Bornhauser M, et al. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica, 2009, 94(8): 1151-1156.
  • 8Zhang X, Jiao C, Zhao S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev, 2009, 5(4): 402-409.
  • 9Xie H, Yang F, Deng L, et al. The performance of a bone-derived scaffold material in the repair of critical bone defects in a rhesus monkey model. Biomaterials, 2007, 28(22): 3314-3324.
  • 10Dai F, Shi D, He W, et al. hCTLA4-gene modified human bone marrow-derived mesenchymal stem cells as allogeneic seed cells in bone tissue engineering. Tissue Eng, 2006, 12(9): 2583-2590.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部